 | • レポートコード：GIR-2104Z10972 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、血漿由来医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血漿由来医薬品の種類別市場規模（アルブミン、凝固因子、免疫グロブリン、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・血漿由来医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Grifols、SK Plasma、Fusion Health Care、Biotest AG、GC Pharma、Baxter International、LFB、Octapharma AG、CSL Limited、BPL、China Biologic Products、Kedrion Biopharma、RAAS、Tiantan Bio、Hualan Biological Engineering、BOYA Bio-Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アルブミン、凝固因子、免疫グロブリン、その他 ・用途別分析2016年-2026年：病院、診療所、その他 ・血漿由来医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血漿由来医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血漿由来医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血漿由来医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血漿由来医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Plasma Derived Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Plasma Derived Medicine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Plasma Derived Medicine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Plasma Derived Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Albumin
Coagulation Factor
Immunoglobulin
Others
Market segment by Application can be divided into
Hospitals
Clinics
Other
The key market players for global Plasma Derived Medicine market are listed below:
Grifols
SK Plasma
Fusion Health Care
Biotest AG
GC Pharma
Baxter International
LFB
Octapharma AG
CSL Limited
BPL
China Biologic Products
Kedrion Biopharma
RAAS
Tiantan Bio
Hualan Biological Engineering
BOYA Bio-Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Plasma Derived Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma Derived Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Albumin
1.2.3 Coagulation Factor
1.2.4 Immunoglobulin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma Derived Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Plasma Derived Medicine Market Size & Forecast
1.4.1 Global Plasma Derived Medicine Sales in Value (2016-2026))
1.4.2 Global Plasma Derived Medicine Sales in Volume (2016-2026)
1.4.3 Global Plasma Derived Medicine Price by Type (2016-2026) & (USD/MT)
1.5 Global Plasma Derived Medicine Production Capacity Analysis
1.5.1 Global Plasma Derived Medicine Total Production Capacity (2016-2026)
1.5.2 Global Plasma Derived Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma Derived Medicine Market Drivers
1.6.2 Plasma Derived Medicine Market Restraints
1.6.3 Plasma Derived Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Plasma Derived Medicine Product and Services
2.1.4 Grifols Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 SK Plasma
2.2.1 SK Plasma Details
2.2.2 SK Plasma Major Business
2.2.3 SK Plasma Plasma Derived Medicine Product and Services
2.2.4 SK Plasma Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Fusion Health Care
2.3.1 Fusion Health Care Details
2.3.2 Fusion Health Care Major Business
2.3.3 Fusion Health Care Plasma Derived Medicine Product and Services
2.3.4 Fusion Health Care Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Biotest AG
2.4.1 Biotest AG Details
2.4.2 Biotest AG Major Business
2.4.3 Biotest AG Plasma Derived Medicine Product and Services
2.4.4 Biotest AG Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GC Pharma
2.5.1 GC Pharma Details
2.5.2 GC Pharma Major Business
2.5.3 GC Pharma Plasma Derived Medicine Product and Services
2.5.4 GC Pharma Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Baxter International
2.6.1 Baxter International Details
2.6.2 Baxter International Major Business
2.6.3 Baxter International Plasma Derived Medicine Product and Services
2.6.4 Baxter International Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 LFB
2.7.1 LFB Details
2.7.2 LFB Major Business
2.7.3 LFB Plasma Derived Medicine Product and Services
2.7.4 LFB Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Octapharma AG
2.8.1 Octapharma AG Details
2.8.2 Octapharma AG Major Business
2.8.3 Octapharma AG Plasma Derived Medicine Product and Services
2.8.4 Octapharma AG Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 CSL Limited
2.9.1 CSL Limited Details
2.9.2 CSL Limited Major Business
2.9.3 CSL Limited Plasma Derived Medicine Product and Services
2.9.4 CSL Limited Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 BPL
2.10.1 BPL Details
2.10.2 BPL Major Business
2.10.3 BPL Plasma Derived Medicine Product and Services
2.10.4 BPL Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 China Biologic Products
2.11.1 China Biologic Products Details
2.11.2 China Biologic Products Major Business
2.11.3 China Biologic Products Plasma Derived Medicine Product and Services
2.11.4 China Biologic Products Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Kedrion Biopharma
2.12.1 Kedrion Biopharma Details
2.12.2 Kedrion Biopharma Major Business
2.12.3 Kedrion Biopharma Plasma Derived Medicine Product and Services
2.12.4 Kedrion Biopharma Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 RAAS
2.13.1 RAAS Details
2.13.2 RAAS Major Business
2.13.3 RAAS Plasma Derived Medicine Product and Services
2.13.4 RAAS Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Tiantan Bio
2.14.1 Tiantan Bio Details
2.14.2 Tiantan Bio Major Business
2.14.3 Tiantan Bio Plasma Derived Medicine Product and Services
2.14.4 Tiantan Bio Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Hualan Biological Engineering
2.15.1 Hualan Biological Engineering Details
2.15.2 Hualan Biological Engineering Major Business
2.15.3 Hualan Biological Engineering Plasma Derived Medicine Product and Services
2.15.4 Hualan Biological Engineering Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 BOYA Bio-Pharmaceutical
2.16.1 BOYA Bio-Pharmaceutical Details
2.16.2 BOYA Bio-Pharmaceutical Major Business
2.16.3 BOYA Bio-Pharmaceutical Plasma Derived Medicine Product and Services
2.16.4 BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Plasma Derived Medicine Sales by Manufacturer
3.1 Global Plasma Derived Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Plasma Derived Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Plasma Derived Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Derived Medicine Manufacturer Market Share
3.4.2 Top 6 Plasma Derived Medicine Manufacturer Market Share
3.5 Global Plasma Derived Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Plasma Derived Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma Derived Medicine Market Size by Region
4.1.1 Global Plasma Derived Medicine Sales in Volume by Region (2016-2026)
4.1.2 Global Plasma Derived Medicine Revenue by Region (2016-2026)
4.2 North America Plasma Derived Medicine Revenue (2016-2026)
4.3 Europe Plasma Derived Medicine Revenue (2016-2026)
4.4 Asia-Pacific Plasma Derived Medicine Revenue (2016-2026)
4.5 South America Plasma Derived Medicine Revenue (2016-2026)
4.6 Middle East and Africa Plasma Derived Medicine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Plasma Derived Medicine Sales in Volume by Type (2016-2026)
5.2 Global Plasma Derived Medicine Revenue by Type (2016-2026)
5.3 Global Plasma Derived Medicine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Plasma Derived Medicine Sales in Volume by Application (2016-2026)
6.2 Global Plasma Derived Medicine Revenue by Application (2016-2026)
6.3 Global Plasma Derived Medicine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Plasma Derived Medicine Sales by Type (2016-2026)
7.2 North America Plasma Derived Medicine Sales by Application (2016-2026)
7.3 North America Plasma Derived Medicine Market Size by Country
7.3.1 North America Plasma Derived Medicine Sales in Volume by Country (2016-2026)
7.3.2 North America Plasma Derived Medicine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma Derived Medicine Sales by Type (2016-2026)
8.2 Europe Plasma Derived Medicine Sales by Application (2016-2026)
8.3 Europe Plasma Derived Medicine Market Size by Country
8.3.1 Europe Plasma Derived Medicine Sales in Volume by Country (2016-2026)
8.3.2 Europe Plasma Derived Medicine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Plasma Derived Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Plasma Derived Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Plasma Derived Medicine Market Size by Region
9.3.1 Asia-Pacific Plasma Derived Medicine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Plasma Derived Medicine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Plasma Derived Medicine Sales by Type (2016-2026)
10.2 South America Plasma Derived Medicine Sales by Application (2016-2026)
10.3 South America Plasma Derived Medicine Market Size by Country
10.3.1 South America Plasma Derived Medicine Sales in Volume by Country (2016-2026)
10.3.2 South America Plasma Derived Medicine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma Derived Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Plasma Derived Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Plasma Derived Medicine Market Size by Country
11.3.1 Middle East & Africa Plasma Derived Medicine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Plasma Derived Medicine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Plasma Derived Medicine Typical Distributors
12.3 Plasma Derived Medicine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Plasma Derived Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Plasma Derived Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Plasma Derived Medicine Product and Services
Table 6. Grifols Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. SK Plasma Basic Information, Manufacturing Base and Competitors
Table 8. SK Plasma Major Business
Table 9. SK Plasma Plasma Derived Medicine Product and Services
Table 10. SK Plasma Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Fusion Health Care Basic Information, Manufacturing Base and Competitors
Table 12. Fusion Health Care Major Business
Table 13. Fusion Health Care Plasma Derived Medicine Product and Services
Table 14. Fusion Health Care Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biotest AG Basic Information, Manufacturing Base and Competitors
Table 16. Biotest AG Major Business
Table 17. Biotest AG Plasma Derived Medicine Product and Services
Table 18. Biotest AG Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 20. GC Pharma Major Business
Table 21. GC Pharma Plasma Derived Medicine Product and Services
Table 22. GC Pharma Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Baxter International Basic Information, Manufacturing Base and Competitors
Table 24. Baxter International Major Business
Table 25. Baxter International Plasma Derived Medicine Product and Services
Table 26. Baxter International Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. LFB Basic Information, Manufacturing Base and Competitors
Table 28. LFB Major Business
Table 29. LFB Plasma Derived Medicine Product and Services
Table 30. LFB Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 32. Octapharma AG Major Business
Table 33. Octapharma AG Plasma Derived Medicine Product and Services
Table 34. Octapharma AG Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 36. CSL Limited Major Business
Table 37. CSL Limited Plasma Derived Medicine Product and Services
Table 38. CSL Limited Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. BPL Basic Information, Manufacturing Base and Competitors
Table 40. BPL Major Business
Table 41. BPL Plasma Derived Medicine Product and Services
Table 42. BPL Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 44. China Biologic Products Major Business
Table 45. China Biologic Products Plasma Derived Medicine Product and Services
Table 46. China Biologic Products Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 48. Kedrion Biopharma Major Business
Table 49. Kedrion Biopharma Plasma Derived Medicine Product and Services
Table 50. Kedrion Biopharma Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. RAAS Basic Information, Manufacturing Base and Competitors
Table 52. RAAS Major Business
Table 53. RAAS Plasma Derived Medicine Product and Services
Table 54. RAAS Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 56. Tiantan Bio Major Business
Table 57. Tiantan Bio Plasma Derived Medicine Product and Services
Table 58. Tiantan Bio Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 60. Hualan Biological Engineering Major Business
Table 61. Hualan Biological Engineering Plasma Derived Medicine Product and Services
Table 62. Hualan Biological Engineering Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. BOYA Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. BOYA Bio-Pharmaceutical Major Business
Table 65. BOYA Bio-Pharmaceutical Plasma Derived Medicine Product and Services
Table 66. BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Plasma Derived Medicine Sales by Manufacturer (2019-2021e) & (K MT)
Table 68. Global Plasma Derived Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Plasma Derived Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Plasma Derived Medicine Production Capacity by Company, (K MT): 2020 VS 2021
Table 71. Head Office and Plasma Derived Medicine Production Site of Key Manufacturer
Table 72. Global Plasma Derived Medicine Sales by Region (2016-2021e) & (K MT)
Table 73. Global Plasma Derived Medicine Sales by Region (2021-2026) & (K MT)
Table 74. Global Plasma Derived Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Plasma Derived Medicine Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Plasma Derived Medicine Sales by Type (2016-2021e) & (K MT)
Table 77. Global Plasma Derived Medicine Sales by Type (2021-2026) & (K MT)
Table 78. Global Plasma Derived Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Plasma Derived Medicine Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Plasma Derived Medicine Price by Type (2016-2021e) & (USD/MT)
Table 81. Global Plasma Derived Medicine Price by Type (2021-2026) & (USD/MT)
Table 82. Global Plasma Derived Medicine Sales by Application (2016-2021e) & (K MT)
Table 83. Global Plasma Derived Medicine Sales by Application (2021-2026) & (K MT)
Table 84. Global Plasma Derived Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Plasma Derived Medicine Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Plasma Derived Medicine Price by Application (2016-2021e) & (USD/MT)
Table 87. Global Plasma Derived Medicine Price by Application (2021-2026) & (USD/MT)
Table 88. North America Plasma Derived Medicine Sales by Country (2016-2021e) & (K MT)
Table 89. North America Plasma Derived Medicine Sales by Country (2021-2026) & (K MT)
Table 90. North America Plasma Derived Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Plasma Derived Medicine Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Plasma Derived Medicine Sales by Type (2016-2021e) & (K MT)
Table 93. North America Plasma Derived Medicine Sales by Type (2021-2026) & (K MT)
Table 94. North America Plasma Derived Medicine Sales by Application (2016-2021e) & (K MT)
Table 95. North America Plasma Derived Medicine Sales by Application (2021-2026) & (K MT)
Table 96. Europe Plasma Derived Medicine Sales by Country (2016-2021e) & (K MT)
Table 97. Europe Plasma Derived Medicine Sales by Country (2021-2026) & (K MT)
Table 98. Europe Plasma Derived Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Plasma Derived Medicine Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Plasma Derived Medicine Sales by Type (2016-2021e) & (K MT)
Table 101. Europe Plasma Derived Medicine Sales by Type (2021-2026) & (K MT)
Table 102. Europe Plasma Derived Medicine Sales by Application (2016-2021e) & (K MT)
Table 103. Europe Plasma Derived Medicine Sales by Application (2021-2026) & (K MT)
Table 104. Asia-Pacific Plasma Derived Medicine Sales by Region (2016-2021e) & (K MT)
Table 105. Asia-Pacific Plasma Derived Medicine Sales by Region (2021-2026) & (K MT)
Table 106. Asia-Pacific Plasma Derived Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Plasma Derived Medicine Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Plasma Derived Medicine Sales by Type (2016-2021e) & (K MT)
Table 109. Asia-Pacific Plasma Derived Medicine Sales by Type (2021-2026) & (K MT)
Table 110. Asia-Pacific Plasma Derived Medicine Sales by Application (2016-2021e) & (K MT)
Table 111. Asia-Pacific Plasma Derived Medicine Sales by Application (2021-2026) & (K MT)
Table 112. South America Plasma Derived Medicine Sales by Country (2016-2021e) & (K MT)
Table 113. South America Plasma Derived Medicine Sales by Country (2021-2026) & (K MT)
Table 114. South America Plasma Derived Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Plasma Derived Medicine Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Plasma Derived Medicine Sales by Type (2016-2021e) & (K MT)
Table 117. South America Plasma Derived Medicine Sales by Type (2021-2026) & (K MT)
Table 118. South America Plasma Derived Medicine Sales by Application (2016-2021e) & (K MT)
Table 119. South America Plasma Derived Medicine Sales by Application (2021-2026) & (K MT)
Table 120. Middle East & Africa Plasma Derived Medicine Sales by Country (2016-2021e) & (K MT)
Table 121. Middle East & Africa Plasma Derived Medicine Sales by Country (2021-2026) & (K MT)
Table 122. Middle East & Africa Plasma Derived Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Plasma Derived Medicine Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Plasma Derived Medicine Sales by Type (2016-2021e) & (K MT)
Table 125. Middle East & Africa Plasma Derived Medicine Sales by Type (2021-2026) & (K MT)
Table 126. Middle East & Africa Plasma Derived Medicine Sales by Application (2016-2021e) & (K MT)
Table 127. Middle East & Africa Plasma Derived Medicine Sales by Application (2021-2026) & (K MT)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Plasma Derived Medicine Typical Distributors
Table 131. Plasma Derived Medicine Typical Customers
List of Figures
Figure 1. Plasma Derived Medicine Picture
Figure 2. Global Plasma Derived Medicine Sales Market Share by Type in 2020
Figure 3. Albumin
Figure 4. Coagulation Factor
Figure 5. Immunoglobulin
Figure 6. Others
Figure 7. Global Plasma Derived Medicine Sales Market Share by Application in 2020
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Plasma Derived Medicine Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Plasma Derived Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Plasma Derived Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Plasma Derived Medicine Sales (2016-2026) & (K MT)
Figure 33. Global Plasma Derived Medicine Production Capacity (2016-2026) & (K MT)
Figure 34. Global Plasma Derived Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Plasma Derived Medicine Market Drivers
Figure 36. Plasma Derived Medicine Market Restraints
Figure 37. Plasma Derived Medicine Market Trends
Figure 38. Global Plasma Derived Medicine Sales Market Share by Manufacturer in 2020
Figure 39. Global Plasma Derived Medicine Revenue Market Share by Manufacturer in 2020
Figure 40. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Plasma Derived Medicine Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Plasma Derived Medicine Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Plasma Derived Medicine Sales Market Share by Region (2016-2026)
Figure 44. Global Plasma Derived Medicine Revenue Market Share by Region (2016-2026)
Figure 45. North America Plasma Derived Medicine Revenue (2016-2026) & (USD Million)
Figure 46. Europe Plasma Derived Medicine Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Plasma Derived Medicine Revenue (2016-2026) & (USD Million)
Figure 48. South America Plasma Derived Medicine Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Plasma Derived Medicine Revenue (2016-2026) & (USD Million)
Figure 50. Global Plasma Derived Medicine Sales Market Share by Type (2016-2026)
Figure 51. Global Plasma Derived Medicine Revenue Market Share by Type (2016-2026)
Figure 52. Global Plasma Derived Medicine Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Plasma Derived Medicine Sales Market Share by Application (2016-2026)
Figure 54. Global Plasma Derived Medicine Revenue Market Share by Application (2016-2026)
Figure 55. Global Plasma Derived Medicine Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Plasma Derived Medicine Sales Market Share by Country (2016-2026)
Figure 57. North America Plasma Derived Medicine Revenue Market Share by Country (2016-2026)
Figure 58. North America Plasma Derived Medicine Sales Market Share by Type (2016-2026)
Figure 59. North America Plasma Derived Medicine Sales Market Share by Application (2016-2026)
Figure 60. Europe Plasma Derived Medicine Sales Market Share by Country (2016-2026)
Figure 61. Europe Plasma Derived Medicine Revenue Market Share by Country (2016-2026)
Figure 62. Europe Plasma Derived Medicine Sales Market Share by Type (2016-2026)
Figure 63. Europe Plasma Derived Medicine Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Plasma Derived Medicine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Plasma Derived Medicine Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Plasma Derived Medicine Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Plasma Derived Medicine Sales Market Share by Application (2016-2026)
Figure 68. South America Plasma Derived Medicine Sales Market Share by Country (2016-2026)
Figure 69. South America Plasma Derived Medicine Revenue Market Share by Country (2016-2026)
Figure 70. South America Plasma Derived Medicine Sales Market Share by Type (2016-2026)
Figure 71. South America Plasma Derived Medicine Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Plasma Derived Medicine Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Plasma Derived Medicine Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のヒト血漿由来治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…- 世界の糖型界面活性剤市場 2021：企業別、地域別、種類・用途別 The Sugar Derived Surfactant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の植物・植物由来薬剤市場規模・現状・予測（2021年-2027年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- 世界のプラズマ治療薬市場規模・現状・予測（2021年-2027年） Plasma, pale yellow in color, is the component of the blood. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI. M…
- 世界の血漿タンパク質治療薬市場規模・現状・予測（2021年-2027年） Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product…